The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

W.

Forum Topics Started

Viewing 6 topics - 1 through 6 (of 6 total)

- TOPIC
- Beta blockers as adjuvant treatment?
  Started by: W. General Melanoma Community
- 3
- 15
- bradcope1
  
  14 years, 1 month ago
- “WHEN YOUR LOVED ONE IS NOT HIMSELF”
  Started by: W. Caregiver Community
- 0
- 0
- W.
  
  14 years, 10 months ago
- Interesting article about drug development (elesclomol)
  Started by: W. General Melanoma Community
- 0
- 0
- W.
  
  14 years, 11 months ago
- BRAF expanded access now on clinicaltrials.gov
  Started by: W. General Melanoma Community
- 1
- 2
- Lauren mom to Jenna
  
  14 years, 12 months ago
- Interesting article in New York Times
  Started by: W. General Melanoma Community
- 9
- 20
- tsoemd
  
  15 years, 2 months ago
- Hey Sharon in Reno
  Started by: W. General Melanoma Community
- 2
- 4
- Shelly in Switzerland
  
  15 years, 3 months ago

Viewing 6 topics - 1 through 6 (of 6 total)

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.